Adrenolipoma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Marjan Khan (talk | contribs) |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenolipoma}} | {{Adrenolipoma}} | ||
{{CMG}} {{AE}} {{AAM}} | |||
==Overview== | ==Overview== | ||
Surgery is the mainstay of treatment of large adrenolipomas. | |||
==Surgery== | ==Surgery== | ||
Surgery is the mainstay of treatment of large adrenolipomas. | |||
*Management of adrenal myelolipoma is decided based upon the size of lesion and presence of symptoms. | |||
*Small lesions measuring less than 5 cm, and those who are asymptomatic are usually monitored via imaging over a period of one to two years. | |||
*Symptomatic tumors or myelolipomas larger than 7 cm should undergo elective surgical excision. | |||
*The approach is based on the reported incidence of life-threatening emergencies caused by spontaneous rupture and hemorrhage within large lesions. | |||
*Conventional or endoscopic access may be chosen according to the size of the tumor. | |||
*Mini-invasive and endoscopic techniques are best utilized for smaller-sized lesions, depending on the expertise of the operator. | |||
*Conventional methods including transabdominal, lumbar, subcostal or posterior access laparotomy operations have all been described in the literature. | |||
*An extraperitoneal approach is preferable as it leads to quicker recovery of the patient and lesser postoperative complications. | |||
*The midline approach is indicated for masses larger than 10 cm or in cases where there are adhesions and infiltration of the surrounding structures. | |||
*Follow up is mandatory regardless of which surgical method has been employed. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Oncology]] | |||
[[Category:Endocrine system]] | [[Category:Endocrine system]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 00:25, 4 October 2019
|
Adrenolipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenolipoma surgery On the Web |
|
American Roentgen Ray Society Images of Adrenolipoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Surgery is the mainstay of treatment of large adrenolipomas.
Surgery
Surgery is the mainstay of treatment of large adrenolipomas.
- Management of adrenal myelolipoma is decided based upon the size of lesion and presence of symptoms.
- Small lesions measuring less than 5 cm, and those who are asymptomatic are usually monitored via imaging over a period of one to two years.
- Symptomatic tumors or myelolipomas larger than 7 cm should undergo elective surgical excision.
- The approach is based on the reported incidence of life-threatening emergencies caused by spontaneous rupture and hemorrhage within large lesions.
- Conventional or endoscopic access may be chosen according to the size of the tumor.
- Mini-invasive and endoscopic techniques are best utilized for smaller-sized lesions, depending on the expertise of the operator.
- Conventional methods including transabdominal, lumbar, subcostal or posterior access laparotomy operations have all been described in the literature.
- An extraperitoneal approach is preferable as it leads to quicker recovery of the patient and lesser postoperative complications.
- The midline approach is indicated for masses larger than 10 cm or in cases where there are adhesions and infiltration of the surrounding structures.
- Follow up is mandatory regardless of which surgical method has been employed.